• Zum Hauptinhalt springen
  • Zum Footer springen
  • Deutsch - de
  • English - en

    SyNergy - Mu...

    • About
      • About us
      • Our Measures
      • Members
      • Cluster Management
      •  PhD & Postdoc representatives
      • Scientific Advisory Board
      •  International cooperation partners
      • Timeline
      •  Media Kit
      • Contact
    • News & Events
      • News
      • Events
      • In the News
      • Open Positions
    • Research
      • Publications
      • Our Research Focus
      • Technology Hubs
      • Research Spotlight
      • Research Data Management
      • Sustainability Initiative
      •  Code of Conduct
    • Science & Society
      • For Schools & Students
      • Public Events
      • Podcasts
      • Videos
    • Support for Diversity & Equity
      • Newcomer Center
      • Gender Equality Program
      • Early Career Investigator Program
    1. Home
    2. News & Events
    3. News
    4. Coronavirus - Neuropilin-1 could open the door to the inside of the cell
    News | 20/10/2020 | Press Release

    Coronavirus - Neuropilin-1 could open the door to the inside of the cell

    How the virus enters the cell: The protein neuropilin-1 facilitates SARS CoV-2 cell entry. A research team including SyNergy member Prof. Mikael Simons of the Technical University of Munich (TUM) recently published these findings in the journal "Science". Because neuropilin-1 is expressed in the mucous membranes of the olfactory and respiratory tract, the findings may be important for understanding the spreading of SARS CoV-2. components for this phenomenon have so far remained elusive.

    The degree to which a virus spreads depends on its infectivity. While the coronavirus SARS-CoV-2 has led to severe pandemic, a related virus, SARS-CoV, led to a much smaller outbreak in 2003, possibly because the infection was limited to the lower respiratory system. SARS-CoV-2, in contrast, infects the upper portions of the respiratory tract, including the nasal mucous membrane and, in consequence, spreads rapidly through active viral shedding. Researchers at TUM, the German Center for Neurodegenerative Diseases (DZNE), the University Clinic Universitätsmedizin Göttingen and the University of Helsinki have investigated the nature of SARS-CoV-2 infectivity.

    • Press release TUM
    • Press release DZNE

    Participating Universities
     LMU logo in white
     TUM logo in white
    Partner Institutions
     Logo DZNE in white
    Helmholtz Munich logo in white 
     Logo Max Planck Gesellschaft 

    SyNergy is funded by the Deutsche Forschungsgemeinschaft (German Research Foundation) within the framework of the German Excellence Strategy (EXC 2145 SyNergy – ID 390857198). The Excellence Strategy promotes outstanding research at German universities. 

    Contact

    Munich Cluster for Systems Neurology (SyNergy)

    Feodor-Lynen-Str. 17
    81377 Munich
    +49 (0)89 4400-46497
    ,yaüubgybcјuWipxј_vfJulyzemi
    Editor login
    Imprint | Data-Safety